Hypoxia-inducible CAR expression: An answer to the on-target/off-tumor dilemma?

por Prinzing, Brooke, Krenciute, Giedre
Publicado 2021

Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma

por Yi, Zhongzhen, Prinzing, Brooke L., Cao, Felicia, Gottschalk, Stephen, Krenciute, Giedre
Publicado 2018

MyD88/CD40 signaling retains CAR T cells in a less differentiated state

por Prinzing, Brooke, Schreiner, Patrick, Bell, Matthew, Fan, Yiping, Krenciute, Giedre, Gottschalk, Stephen
Publicado 2020

RASA2 ablation in T cells boosts antigen sensitivity and long-term function

por Carnevale, Julia, Shifrut, Eric, Kale, Nupura, Nyberg, William A., Blaeschke, Franziska, Chen, Yan Yi, Li, Zhongmei, Bapat, Sagar P., Diolaiti, Morgan E., O’Leary, Patrick, Vedova, Shane, Belk, Julia, Daniel, Bence, Roth, Theodore L., Bachl, Stefanie, Anido, Alejandro Allo, Prinzing, Brooke, Ibañez-Vega, Jorge, Lange, Shannon, Haydar, Dalia, Luetke-Eversloh, Marie, Born-Bony, Maelys, Hegde, Bindu, Kogan, Scott, Feuchtinger, Tobias, Okada, Hideho, Satpathy, Ansuman T., Shannon, Kevin, Gottschalk, Stephen, Eyquem, Justin, Krenciute, Giedre, Ashworth, Alan, Marson, Alexander
Publicado 2022